Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
BeOne Medicines reported third quarter 2026 total global revenues of $1.9 billion, a 34% increase year-over-year, driven by strong sales of its BTK inhibitor BRUKINSA. The company achieved GAAP net income of $384.7 million and raised its full-year 2026 revenue guidance to a range of $6.9 billion to $7.0 billion.
Term
3 months
“Our strong third quarter results and raised full-year guidance reflect continued rapid global growth and leadership in hematology, anchored by our foundational BTK inhibitor BRUKINSA, which drives powerful and sustained responses in patients, and now joined by our next-generation BCL2 inhibitor BEQALZI.”
Primo Brands reported Q3 2026 net sales of $1.82 billion, a 3.1% increase driven by premium brands and regional spring water. The company also announced a new $300 million share repurchase program and updated its full-year 2026 outlook, expecting net sales at the midpoint and Adjusted EBITDA at the lower end of previous guidance.
Term
Q3 2026
“Our third quarter results demonstrate solid top-line momentum and improving execution across the business. This led to Direct Delivery growth ahead of our expectations, broad-based Retail sales growth, and category dollar share gains.”
Eric Foss, Chairman and Chief Executive Officer
“Our new $300 million share repurchase program provides another avenue to continue to return capital to shareholders, while maintaining focus on investing for long-term growth and reducing net leverage.”
Novelis reported second quarter fiscal year 2027 results with net sales increasing 25% year-over-year to $5.9 billion, driven by higher aluminum prices. Net income rose 29% to $210 million, supported by insurance recoveries from the 2025 Oswego fires and favorable metal benefits.
Term
Q2 2027
“We delivered strong quarterly results, reflecting disciplined execution, resilient demand and favorable market conditions. We are excited about the opportunities ahead as Bay Minette moves closer to commercial production, increasing our ability to serve the undersupplied North American market.”
Steve Fisher, president and CEO, Novelis Inc.
“As Bay Minette transitions from construction to start-up, reduced capital spending, continued cost discipline and solid underlying business conditions are expected to drive a return to positive free cash flow and mark the beginning of a deleveraging cycle toward the end of this fiscal year.”
Dev Ahuja, executive vice president and CFO, Novelis Inc.
Celsius Holdings reported record third-quarter revenue of $847.2 million, a 17% increase year-over-year, driven by strong performance from the Alani Nu brand. Net income rose significantly to $127.0 million compared to a loss in the prior year, though gross margins compressed by 450 basis points to 46.8%.
Term
Q3 2026
“We delivered record quarterly revenue in the third quarter of 2026, reflecting the strength of our scaled, multi-brand Modern Energy platform and continued execution of our total energy portfolio strategy.”
John Fieldly, Chairman and CEO of Celsius Holdings
Arhaus reported third quarter 2026 net revenue of $368 million, a 6.8% increase year-over-year, driven by strong client demand and 13.9% growth in comparable written sales. Net income decreased 36% to $8 million as the company continued investments in its showroom network, including the relocation of its second-largest showroom in Charlotte, North Carolina.
Term
Q3 2026
“For 40 years, Arhaus has been defined by exceptional craftsmanship, timeless design, and distinctive products. Our continued investment in compelling new collections and expanded customization is resonating with clients, as reflected in third-quarter Comparable Written Sales growth of 13.9%.”
John Reed, Co-Founder and Chief Executive Officer
“We are pleased with our third-quarter performance, which reflects strong client demand, disciplined execution, and continued progress across our strategic priorities. Our investments in our people, infrastructure, and technology are strengthening our foundation and positioning Arhaus for sustainable, profitable long-term growth.”
Haemonetics reported second quarter fiscal 2027 revenue of $358 million, a 9% increase driven by strong performance in its Apheresis business. The company achieved GAAP diluted EPS of $1.00 and adjusted diluted EPS of $1.35, benefiting from gross margin expansion and the transformation of its product portfolio toward higher-margin offerings.
Term
Q2 2027
“Our second-quarter and first-half results reflect significant momentum across our businesses. Expansion of our CSL relationship and recent innovation milestones in both Apheresis and MedSurg strengthen our competitive position and create powerful new opportunities. With multiple catalysts for growth, we are focused on executing for our customers and translating our momentum into sustained success and shareholder value.”
InMed Pharmaceuticals Inc. (renamed Mentari Therapeutics, Inc.) completed a 1-for-10 reverse stock split (consolidation) of its common shares effective November 4, 2026. The split reduced the outstanding share count from approximately 5.49 million to 0.55 million shares to facilitate its pending merger and reorganization with Mentari Therapeutics, Inc. (Delaware).
Icahn Enterprises L.P. filed an updated investor presentation for November 2026 to be used in meetings with investors and media. The presentation includes strategic updates and forward-looking statements regarding its investment activities and energy business, including potential refining asset acquisitions by CVR Energy.
3D Systems $92M Debt Financing with Institutional accredited investors
3D Systems entered into exchange agreements to retire all $92.03 million of its outstanding 5.875% Convertible Senior Secured Notes due 2030. In exchange, the company will issue $85 million in new 3.30% Convertible Senior Notes due 2031, pay $20 million in cash, and issue approximately 13.5 million shares of common stock. This transaction effectively eliminates all of the company's secured debt and extends its debt maturity profile.
Value
$92M
Counterparty
Institutional accredited investors and qualified institutional buyers
Eve Holding, Inc. reported a net loss of $161.1 million for the nine months ended September 30, 2026, as it continues to invest heavily in eVTOL research and development. The company's total liabilities increased significantly to $443.9 million, primarily due to a rise in long-term debt, resulting in a total equity deficit of $34.5 million.
Vistra Signs $2.2B M&A Deal with Q-Generation Holdings, LLC
Vistra Corp. completed its acquisition of Cogentrix Energy from funds managed by Quantum Capital Group for approximately $2.2 billion in cash and 5 million shares of common stock. The deal adds 10 natural gas generation facilities totaling approximately 5,500 MW of capacity across the PJM, ISO-NE, and ERCOT markets, bringing Vistra's total generation portfolio to nearly 50,000 MW.
Value
$2.2B
Counterparty
Q-Generation Holdings, LLC
“Natural gas plays a critical role in meeting our nation’s growing energy needs, and the Cogentrix assets are a strong strategic fit for Vistra as we continue to grow our generation portfolio. We’re excited to bring these experienced teams together around a shared commitment to safety, operational excellence, and reliability. Our Vistra team knows how to successfully integrate generation assets into our fleet, and we look forward to building on Cogentrix’s strengths and delivering long-term value for our stakeholders.”
Jim Burke, president and chief executive officer of Vistra
Prestige Consumer Healthcare reported Q2 fiscal 2027 revenue of $336.3 million, a 22.7% increase driven by the acquisitions of Breathe Right and LaCorium. Adjusted diluted EPS rose to $1.13 from $1.07 in the prior year, supported by strong consumption across eCommerce channels. The company adjusted its full-year revenue guidance to a range of $1.28 billion to $1.29 billion.
Term
Q2 2027
“We were pleased with our second quarter and first half revenue and EPS performance, driven by continued strength in our leading brands and strong early contributions from the Breathe Right® portfolio and LaCorium acquisitions that closed in June and July, respectively. Our portfolio performed in line with our expectations, with strong consumption growth across channels including eCommerce. This translated into strong mid-single-digit earnings growth and sets us up for continued strong free cash flow moving forward.”
Ron Lombardi, Chief Executive Officer of Prestige Consumer Healthcare
ProFrac Holding Corp. reported third quarter 2026 revenue of $511 million and a net loss of $74 million. The company noted that while activity was uneven in Q3 due to downtime, utilization has improved in Q4 with pricing gradually increasing as industry demand for services in 2027 is expected to exceed deployable supply.
Term
Q3 2026
“The market backdrop for hydraulic fracturing continues to tighten with limited available capacity, particularly for natural gas capable equipment. We experienced uneven activity in the third quarter, due to unanticipated white space and downtime, however fourth quarter utilization has improved with a more efficient calendar.”
Matt Wilks, Chief Executive Officer and Executive Chairman
“Industry demand for services in 2027 currently appears to exceed deployable supply. Further, although hydraulic fracturing economics are improving, we believe capital discipline will exacerbate tightening supply demand balances for equipment.”
Matt Wilks, Chief Executive Officer and Executive Chairman
Yum China reported total revenues of $3.48 billion for the quarter ended September 30, 2026, a 8% increase year-over-year, with net income rising to $311 million. The company significantly increased its short-term borrowings to $1.55 billion and completed a $1.2 billion acquisition of intangible assets during the period.
Cadeler plc has completed a redomiciliation from Denmark to the United Kingdom via a voluntary exchange offer, establishing itself as the successor issuer to Cadeler A/S. As a result, Cadeler plc's ordinary shares have commenced trading on the NYSE and Oslo Stock Exchange under the symbols 'CDLR' and 'CADLR' respectively, replacing the previous Cadeler A/S ADSs and shares.
Comfort Systems USA announced that its Board of Directors approved an amendment to its stock repurchase program, authorizing the acquisition of up to 1,000,000 additional shares of common stock. This action 'tops off' the existing program, which had previously repurchased 11,752,570 shares for approximately $1.71 billion as of November 4, 2026. The company intends to finance these discretionary open-market or private repurchases using available cash.
Walker & Dunlop reported Q3 2026 financial results, including a net loss of $37.3 million primarily due to charges for the accelerated resolution of legacy loan repurchases related to GSE investigations. Despite a 12% revenue decline to $298.4 million, the company noted its GSE market share increased to 13.7% and its servicing portfolio grew 5% to $146.6 billion.
Term
Q3 2026
“Q3 2026 saw an 84 basis point increase in the Ten-Year Treasury rate which increased volatility and slowed down capital markets activity across the country. Despite these headwinds, our revenues remained resilient, with total debt financing volume down only 5% from Q3 2025.”
Willy Walker, Chairman and CEO
“We believe that the completion of the GSE investigations and the sale of the repurchased loans, allows Walker & Dunlop to move beyond the borrower fraud issues that have consumed us, and our financial performance, for the past two years.”
First Advantage reported Q3 2026 revenue of $465.8 million, representing 13.8% year-over-year growth, and raised its full-year 2026 guidance. The company also announced the acquisition of Data Diver Technologies, an AI-enabled data platform for criminal and court records, to enhance its automated screening capabilities.
Counterparty
Data Diver Technologies, LLC
“We delivered another quarter of outstanding performance, highlighted by nearly 14% revenue growth, increasing margins, strong cash flow, and robust earnings per share growth. Our results reflected sustained positive momentum across our revenue growth algorithm, with continued excellent base growth, solid new logo contribution, successful upsell and cross-sell activity, and consistently high retention.”
Scott Staples, Chief Executive Officer
“On October 31, we celebrated the two-year anniversary of closing the Sterling acquisition. We are executing well and realizing benefits far exceeding our original expectations. Today, we are a larger, stronger, and more diversified company, offering customers a broader portfolio of best-of-breed technologies and products backed by greater scale and innovation capabilities.”
Ecovyst reported third quarter 2026 sales of $308.6 million, a 51% increase year-over-year, driven by strong refining margins and the acquisition of the Calabrian sulfur dioxide business. The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $208 million to $212 million and announced plans to repurchase up to $20 million in stock during the second half of 2026.
Term
Q3 2026
“Ecovyst delivered another strong quarter, with third quarter 2026 Adjusted EBITDA of $61 million, up over 6% compared to the year-ago quarter, and above the high end of our guidance range.”
Kurt J. Bitting, Ecovyst’s Chief Executive Officer
“We are again raising our full-year Adjusted EBITDA guidance to a range of $208 million to $212 million, reflecting strong momentum through the first nine months of the year and the shift of a turnaround from the fourth quarter into early 2027.”
Kurt J. Bitting, Ecovyst’s Chief Executive Officer
Emma N. Walmsley, a member of Microsoft's Board of Directors since 2019, has informed the company of her decision not to stand for re-election at the 2026 annual shareholder meeting. She will continue to serve as a director until the meeting, and her departure is not due to any disagreement with the company's operations or policies.
Bioxytran secured a government-issued Free Sale Certificate for its A-SUQAR chewable nutraceutical, a key regulatory milestone for market entry in the UAE and Gulf Cooperation Council region. The certification confirms the product is lawfully manufactured and sold as a health supplement, allowing the company to proceed with product registration in markets with high diabetes prevalence.
For the nine months ended September 30, 2026, NewLake Capital Partners reported total revenue of $36.4 million and net income of $16.1 million, representing a decrease from the $20.6 million earned in the prior year period. The company maintained a portfolio with $428.8 million in total real estate assets and reduced its debt by fully repaying its $7.6 million revolving credit facility during the period.
Blackstone Real Estate Income Trust Investor Presentation
Blackstone Real Estate Income Trust (BREIT) provided a Q3 2026 update highlighting a +2.0% quarterly net return and +7.3% year-to-date performance for Class I shares. The company reported its strongest fundraising quarter since 2022, with year-to-date subscriptions up approximately 40% year-over-year and the launch of a new 1031 DST exchange program, BXREX.
Evergy, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 234,496,657 shares of common stock outstanding as of October 30, 2026. The filing highlights significant growth drivers from data centers and large load customers, while noting risks related to capital access, regulatory outcomes, and the construction of new generation and transmission facilities.
Lemonade reported Q3 2026 financial results featuring 34% growth in In Force Premium to $1.55 billion and a 73% increase in revenue to $336 million. The company narrowed its Adjusted EBITDA loss to $20 million and reiterated its expectation to achieve positive Adjusted EBITDA for the first time in Q4 2026.
Our Bond, Inc. founder and CEO Doron Kempel is hosting a live webinar on November 5, 2026, to provide a company update. The company has furnished a formal presentation deck as Exhibit 99.1 to accompany the webinar.
Evergy Metro, Inc. filed this combined 10-Q as a registrant with reduced disclosure format, reporting only one share of common stock outstanding held by Evergy, Inc. The filing highlights significant risks related to rapid electricity demand growth from data centers and the associated need for new generation and transmission investments.
Evergy Kansas Central, Inc. filed this combined 10-Q as a reduced disclosure registrant, reporting that it remains a wholly-owned subsidiary of Evergy, Inc. with one share of common stock outstanding. The filing highlights risks related to rapid electricity demand growth from data centers and the associated need for significant new generation and transmission investment.
Snap Inc. is a large accelerated filer reporting three classes of common stock with over 1.7 billion total shares outstanding as of October 31, 2026. The company announced a significant reporting transition starting in Q1 2027, moving from Daily Active Users (DAU) to Monthly Active Users (MAU) and MAU-based ARPU as its primary audience and monetization metrics.
Clipper Realty Inc. reported record quarterly revenues of $40.5 million for Q3 2026, driven by strong residential leasing demand and high occupancy. The company reported a net loss of $5.9 million and declared a quarterly dividend of $0.095 per share while continuing to work with lenders regarding the 250 Livingston Street office property.
Term
Q3 2026
“For the quarter, the main highlights are continued strong residential leasing and significant progress made towards resolving lender issues at our 250 Livingston Street office property. The residential properties continued to have high occupancy and strong renter demand. New free market leases exceeded previous rents by 9% and renewals by over 5% and our major residential properties are leased at very high levels. Furthermore, our new Prospect House property at 953 Dean Street in Brooklyn, NY is fully operational after going in service last year.”
David Bistricer, Co-Chairman, and Chief Executive Officer